People

David Sluis

Counsel

Sluis, David L.
David Sluis represents clients in a variety of complex antitrust matters. He routinely advises clients on the antitrust aspects of business combinations subject to FTC and DOJ review under the HSR Act, and has extensive experience in significant antitrust ligation and cartel matters. Mr. Sluis joined the firm in 2012.

Mr. Sluis’ recent merger matters include DOJ investigations in the stock exchange, building products, parking and publishing sectors. Mr. Sluis also represents the head of sales in a DOJ auto parts price fixing investigation, and a leading global auto parts company involved in civil antitrust litigation. Other recent significant matters include assessing the antitrust risks of a standard setting organization, and defending a pharmaceutical company against “reverse payment” actions brought by the FTC and private parties.
 
Prior to joining the firm, Mr. Sluis was an associate at Dechert LLP. During his time there, he represented clients in all aspects of FTC and DOJ antitrust merger investigations.

Prior to joining Dechert, Mr. Sluis served as a summer law intern in the Antitrust Division of the US Department of Justice, where he investigated a potential merger of two leading aluminum producers.

Honors & Awards

  • Selected as a "Rising Star" in the 2016 and 2017 editions of Washington DC Super Lawyers

Publications & News

View

January 29, 2018

HSR Size of Transaction Threshold to Increase to $84.4 Million

The Federal Trade Commission ("FTC") announced revised thresholds for merger notifications under the Hart-Scott-Rodino ("HSR") Act.

April 3, 2017

WilmerHale Reps Vtesse Inc. in Acquisition by Sucampo

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, and Vtesse Inc., a privately-held rare disease company, today announced that Sucampo has acquired Vtesse for upfront consideration of $200 million.

February 14, 2017

WilmerHale Counsels Cynosure in $1.65B Acquisition by Hologic

The WilmerHale team on the transaction was led by Hal Leibowitz and Jason Kropp and included Andrew Bonnes, Kim Wethly, Leon Greenfield, Bruce Manheim, Steve Barrett, Laura Schneider, Amy Null, Julie Hogan Rodgers, Ciara Baker, Davis Sluis, Caroline Dotolo and Alex Civetta.

January 21, 2017

Basic HSR Threshold to Increase to $80.8 Million

The Federal Trade Commission announced revised thresholds for merger notifications under the Hart-Scott-Rodino Act. Once effective, the lowest size-of-transaction filing threshold will increase from the current $78.2 million to $80.8 million.

November 7, 2016

FTC/DOJ Guidance to Human Resource Professionals—Enforcement Scrutiny of Employment-Related Conduct

Last month, the Federal Trade Commission and Department of Justice issued their Antitrust Guidance for Human Resource Professionals. This WilmerHale Client Alert, which was also published by Bloomberg BNA's Antitrust & Trade Regulation Report on November 25, 2016, summarizes the key lessons and practical impact from the HR Guidance for businesses' employment practices.

November 8, 2013

New HSR Rules for Pharmaceutical Patent Licenses

The Federal Trade Commission (“FTC”) this week adopted a significant change to the notification rules under the Hart Scott Rodino (“HSR”) Act that will increase the number of pharmaceutical patent licenses covered by the Act. The amendments apply explicitly only to pharmaceutical patent licenses.

Practices

Skip Navigation Links.

Education

JD, summa cum laude, American University, Washington College of Law, 2008, Member, American University Law Review, Order of the Coif

BA, Economics and Political Science, cum laude, St. Olaf College, 2005

Bar Admissions

District of Columbia

Virginia

Skip Navigation Links.